DK268979A - Fremgangsmaade til fremstilling af octahydro-2h-pyrrolo (3,4-g)quinoliner - Google Patents

Fremgangsmaade til fremstilling af octahydro-2h-pyrrolo (3,4-g)quinoliner

Info

Publication number
DK268979A
DK268979A DK268979A DK268979A DK268979A DK 268979 A DK268979 A DK 268979A DK 268979 A DK268979 A DK 268979A DK 268979 A DK268979 A DK 268979A DK 268979 A DK268979 A DK 268979A
Authority
DK
Denmark
Prior art keywords
quinolines
pyrrolo
octahydro
preparing
preparing octahydro
Prior art date
Application number
DK268979A
Other languages
Danish (da)
English (en)
Inventor
N J Bach
E C Kornfeld
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US06/031,642 external-priority patent/US4235909A/en
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of DK268979A publication Critical patent/DK268979A/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20Oxygen atoms
    • C07D215/22Oxygen atoms attached in position 2 or 4
    • C07D215/227Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 2
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/54Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DK268979A 1979-01-22 1979-06-26 Fremgangsmaade til fremstilling af octahydro-2h-pyrrolo (3,4-g)quinoliner DK268979A (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US506279A 1979-01-22 1979-01-22
US06/031,642 US4235909A (en) 1979-04-19 1979-04-19 Octahydro-2H-pyrrolo[3,4-g]quinolines

Publications (1)

Publication Number Publication Date
DK268979A true DK268979A (da) 1980-07-23

Family

ID=26673871

Family Applications (1)

Application Number Title Priority Date Filing Date
DK268979A DK268979A (da) 1979-01-22 1979-06-26 Fremgangsmaade til fremstilling af octahydro-2h-pyrrolo (3,4-g)quinoliner

Country Status (25)

Country Link
EP (1) EP0013788B1 (ru)
JP (1) JPS55100385A (ru)
AR (1) AR225012A1 (ru)
AT (1) AT365189B (ru)
AU (1) AU528035B2 (ru)
BE (1) BE877328A (ru)
CA (1) CA1131227A (ru)
CH (2) CH641801A5 (ru)
DD (1) DD144668A5 (ru)
DE (1) DE2965277D1 (ru)
DK (1) DK268979A (ru)
ES (1) ES482084A1 (ru)
FI (1) FI65248C (ru)
FR (2) FR2446833A1 (ru)
GB (1) GB2040917B (ru)
IE (1) IE48295B1 (ru)
IL (1) IL57665A (ru)
LU (1) LU81440A1 (ru)
NZ (1) NZ190834A (ru)
PH (2) PH15118A (ru)
PL (1) PL125785B1 (ru)
PT (1) PT69828A (ru)
RO (1) RO77442A (ru)
SU (1) SU1113006A3 (ru)
ZA (1) ZA793244B (ru)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL65269A0 (en) * 1981-03-24 1982-05-31 Lilly Co Eli 6-substituted hexahydroindazolo or hexahydroisoindolo isoquinolines
EP0127708B1 (en) * 1983-06-03 1987-09-09 Eli Lilly And Company Trans-dl-1-alkyl-6-alkoxyoctahydroquinolines
IL73001A0 (en) * 1983-09-26 1984-12-31 Lilly Co Eli Improvements in and relating to 6-oxodecahydroquinolines
US4595754A (en) * 1985-03-04 1986-06-17 Eli Lilly And Company Process for preparing cis N-alkylperhydroquinolines
AR067027A1 (es) * 2007-06-19 2009-09-30 Astrazeneca Ab Derivados de 2, 3-dihidro-1h-pirrol[3, 4b]quinolin-1-ona, una composicion farmaceutica que los comprende y su uso en la fabricacion de un medicamento para el tratamiento de enfermedades mediadas por la modulacion de la actividad del receptor gaba a.
TWI537274B (zh) * 2011-03-14 2016-06-11 橘生藥品工業股份有限公司 新穎之八氫噻吩并喹啉衍生物、含有其之醫藥組成物及該等之用途

Also Published As

Publication number Publication date
IL57665A (en) 1982-11-30
PH15118A (en) 1982-08-10
AU4844479A (en) 1980-07-31
SU1113006A3 (ru) 1984-09-07
DE2965277D1 (en) 1983-06-01
CA1131227A (en) 1982-09-07
IE791210L (en) 1980-10-19
ZA793244B (en) 1981-02-25
FR2446835B1 (ru) 1982-04-23
FI792047A (fi) 1980-07-23
PT69828A (en) 1979-07-01
JPS6233233B2 (ru) 1987-07-20
FI65248C (fi) 1984-04-10
ATA452579A (de) 1981-05-15
EP0013788A1 (en) 1980-08-06
RO77442A (ro) 1982-10-26
AT365189B (de) 1981-12-28
EP0013788B1 (en) 1983-04-27
PL216721A1 (ru) 1980-06-16
FR2446835A1 (fr) 1980-08-14
AR225012A1 (es) 1982-02-15
ES482084A1 (es) 1980-08-01
CH641801A5 (fr) 1984-03-15
GB2040917A (en) 1980-09-03
JPS55100385A (en) 1980-07-31
BE877328A (fr) 1979-12-28
FR2446833B1 (ru) 1982-03-05
LU81440A1 (fr) 1979-09-12
PH16181A (en) 1983-07-25
AU528035B2 (en) 1983-04-14
CH643258A5 (fr) 1984-05-30
FR2446833A1 (fr) 1980-08-14
IL57665A0 (en) 1979-10-31
DD144668A5 (de) 1980-10-29
FI65248B (fi) 1983-12-30
NZ190834A (en) 1984-07-06
GB2040917B (en) 1983-01-06
IE48295B1 (en) 1984-11-28
PL125785B1 (en) 1983-06-30

Similar Documents

Publication Publication Date Title
DK268879A (da) Fremgangsmaade til fremstilling af octahydropyrazolo (3,4-g)-quinoliner
DK155946C (da) Fremgangsmaade til fremstilling af 4,1',6'-trichlor-4,1',6'-tridesoxygalactosaccharose
DK42480A (da) Fremgangsmaade til fremstilling af 1-aryl-2-acylamido-3-fluor-1-propanoler
DK540080A (da) Fremgangsmaade til fremstilling af 2-amino-4-hydroxyquinazolinderivater
DK143401C (da) Fremgangsmaade til fremstilling af 3-substituerede 6a,10a-trans-1-hydroxy-6,6-dimethyl-6,6a,7,8,10,10a-hexahydro-9h-dibenzo-(b,d)pyran-9-oner
DK172182A (da) Fremgangsmaade til fremstilling af 1,4-dihydropyridinderivater
DK157855C (da) Fremgangsmaade til fremstilling af 2,3-dichlor-5-trichlormethylpyridin
DK159681A (da) Fremgangsmaade til fremstilling af 4,5-diaryl-alfa-(polyfluoralkyl)-1h-pyrrol-2-methanaminer
DK156635C (da) Analogifremgangsmaade til fremstilling af 24,24-difluor-25-hydroxycholecalciferol
DK308180A (da) Fremgangsmaade til fremstilling af 2,3-dihydro2,2-dimethyl-7-hydroxybenzofuran
DK268979A (da) Fremgangsmaade til fremstilling af octahydro-2h-pyrrolo (3,4-g)quinoliner
DK174380A (da) Fremgangsmaade til fremstilling af 2!,6!adialkyl-n-alkoxymethyl-2-chlor-acetanillider
DK454579A (da) Fremgangsmaade til fremstilling af 6-piperidino-2,4-diaminopyrimidin-3-oxid
DK113483A (da) Fremgangsmaade til fremstilling af 3,4-diphenyl-5-methylpyrazolderivater
DK418079A (da) Fremgangsmaade til fremstilling af 3,3-substituerede spiro-1,2,4-benzothiadiaziner
DK313580A (da) Fremgangsmaade til fremstilling af 1,2-dihydro-2-oxo-5-(pyridinyl) nicotinonitriler
DK154085C (da) Fremgangsmaade til fremstilling af 1,1-dioxopenicillansyrederivater
DK217480A (da) Fremgangsmaade til fremstilling af 5-mercapto1,2,3-triazoler
DK144885C (da) Fremgangsmaade til fremstilling af 3-substituerede cis-1-hydroxy-6,6-dimethyl-6,6a,7,8,10,10a-hexahydro-9h-dibenzo(b,d)-pyran-9-oner
DK375480A (da) Fremgangsmaade til fremstilling af 1,2,4-triazol-3-thioler
DK513580A (da) Fremgangsmaade til fremstilling af 4,5-diaryl-alfa (polyhalogenalkyl)-1h-imidazol-2-methanoler
DK149962C (da) Fremgangsmaade til fremstilling af 2,5-diketogluconsyre
DK145100C (da) Fremgangsmaade til fremstilling af 3-substituerede cis-1-hydroxy-6,6-dimethyl-6,6a,7,8,10,10a-hexahydro-9h-dibenzo(b,d)pyran-9-oner
DK212080A (da) Fremgangsmaade til fremstilling af 2,2-dialkyl-4-methyl-5,5-dialkyl-3-formyl-3-pyrrolin
DK287480A (da) Fremgangsmaade til fremstilling af 2-isopropylaminopyrimidin

Legal Events

Date Code Title Description
AHS Application shelved for other reasons than non-payment